Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 23 Feb 2021

Concordance of PD-L1 Status Between Image-Guided Percutaneous Biopsies and Matched Surgical Specimen in Non-Small Cell Lung Cancer

in Thoracic Oncology

Liang Zhao
Peiqiong Chen
Kaili Fu
Jinluan Li
Yaqing Dai
Yuhuan Wang
Yanzhen Zhuang
Long Sun
Haojun Chen
Qin Lin

Frontiers in Oncology

doi 10.3389/fonc.2020.551367

2,989 views
6 citations

Systematic Review

Published on 23 Feb 2021

The Impact of Programmed Death-Ligand 1 Expression on the Prognosis of Early Stage Resected Non-Small Cell Lung Cancer: A Meta-Analysis of Literatures

in Thoracic Oncology

Tao Shi
Shuai Zhu
Hengjuan Guo
Xiongfei Li
Shikang Zhao
Yanye Wang
Xi Lei
Dingzhi Huang
Ling Peng
Ziming Li

Frontiers in Oncology

doi 10.3389/fonc.2021.567978

4,537 views
10 citations

Original Research

Published on 17 Feb 2021

The Efficacy and Safety of Anlotinib Combined With PD-1 Antibody for Third-Line or Further-Line Treatment of Patients With Advanced Non-Small-Cell Lung Cancer

in Thoracic Oncology

Chongya Zhai
Xiaoling Zhang
Lulu Ren
Liangkun You
Qin Pan
Hongming Pan
Weidong Han

Frontiers in Oncology

doi 10.3389/fonc.2020.619010

5,051 views
23 citations

Original Research

Published on 15 Feb 2021

Circulating Tumor DNA Analyses as a Potential Marker of Recurrence and Effectiveness of Adjuvant Chemotherapy for Resected Non-Small-Cell Lung Cancer

in Thoracic Oncology

Peng-Peng Kuang
Ning Li
Zui Liu
Tian-Yu Sun
Shu-Quan Wang
Jia Hu
Wei Ou
Si-Yu Wang

Frontiers in Oncology

doi 10.3389/fonc.2020.595650

4,954 views
32 citations

Original Research

Published on 11 Feb 2021

nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+)

in Thoracic Oncology

Daniel Morgensztern
Manuel Cobo Dols
Santiago Ponce Aix
Pieter E. Postmus
Jaafar Bennouna
Jürgen R. Fischer
Oscar Juan-Vidal
David J. Stewart
Andrea Ardizzoni
Rafia Bhore

Frontiers in Oncology

doi 10.3389/fonc.2020.569715

5,692 views
4 citations

Original Research

Published on 08 Feb 2021

Tissue MicroRNA Expression as a Predictor of Response to Immunotherapy in NSCLC Patients

in Thoracic Oncology

Anna Grenda
Paweł Krawczyk
Justyna Błach
Izabela Chmielewska
Tomasz Kubiatowski
Stanisław Kieszko
Kamila Wojas-Krawczyk
Tomasz Kucharczyk
Bożena Jarosz
Iwona Paśnik

Frontiers in Oncology

doi 10.3389/fonc.2020.563613

4,273 views
15 citations

Original Research

Published on 04 Feb 2021

A New Horizon of Liquid Biopsy in Thymic Epithelial Tumors: The Potential Utility of Circulating Cell-Free DNA

in Thoracic Oncology

Margaret Ottaviano
Mario Giuliano
Marianna Tortora
Evelina La Civita
Antonietta Liotti
Michele Longo
Dario Bruzzese
Michele Cennamo
Vittorio Riccio
Pietro De Placido

Frontiers in Oncology

doi 10.3389/fonc.2020.602153

3,140 views
5 citations

Editorial

Published on 03 Feb 2021

Editorial: Epigenetic Modifications in Mesothelioma

in Thoracic Oncology

Yuen Yee Cheng
Man Lee Yuen
Hongchuan Jin

Frontiers in Oncology

doi 10.3389/fonc.2021.650136

2,675 views
2 citations

Original Research

Published on 01 Feb 2021

Weighted-Support Vector Machine Learning Classifier of Circulating Cytokine Biomarkers to Predict Radiation-Induced Lung Fibrosis in Non-Small-Cell Lung Cancer Patients

in Thoracic Oncology

Hao Yu
Ka-On Lam
Huanmei Wu
Michael Green
Weili Wang
Jian-Yue Jin
Chen Hu
Shruti Jolly
Yang Wang
Feng-Ming Spring Kong

Frontiers in Oncology

doi 10.3389/fonc.2020.601979

4,088 views
9 citations

Original Research

Published on 28 Jan 2021

Development of an Oncogenic Driver Alteration Associated Immune-Related Prognostic Model for Stage I-II Lung Adenocarcinoma

in Thoracic Oncology

Jian-Zhao Xu
Chen Gong
Zheng-Fu Xie
Hua Zhao

Frontiers in Oncology

doi 10.3389/fonc.2020.593022

5,131 views
12 citations

Original Research

Published on 28 Jan 2021

Preoperative Folate Receptor-Positive Circulating Tumor Cell Level Is a Prognostic Factor of Long Term Outcome in Non-Small Cell Lung Cancer Patients

in Thoracic Oncology

Hang Li
Bin Li
Yunjian Pan
Yang Zhang
Jiaqing Xiang
Yawei Zhang
Yihua Sun
Xiang Yu
Wei He
Hong Hu

Frontiers in Oncology

doi 10.3389/fonc.2020.621435

3,543 views
13 citations

Original Research

Published on 26 Jan 2021

Upregulation of Long Non-Coding RNA GCC2-AS1 Facilitates Malignant Phenotypes and Correlated With Unfavorable Prognosis for Lung Adenocarcinoma

in Thoracic Oncology

Fengqiang Yu
Mingqiang Liang
Weidong Wu
Yu Huang
Jiantao Zheng
Bin Zheng
Chun Chen

Frontiers in Oncology

doi 10.3389/fonc.2020.628608

2,815 views
9 citations

Original Research

Published on 26 Jan 2021

nab-Paclitaxel/Carboplatin in Vulnerable Populations With Advanced Non-Small Cell Lung Cancer: Pooled Analysis

in Thoracic Oncology

Corey J. Langer
Ajeet Gajra
Cesare Gridelli
Kartik Konduri
Daniel Morgensztern
David Spigel
Denis Talbot
Michael Thomas
Jared Weiss
Richard Pilot

Frontiers in Oncology

doi 10.3389/fonc.2020.485587

6,305 views
5 citations

Case Report

Published on 26 Jan 2021

Case Report: Afatinib Treatment in a Patient With NSCLC Harboring a Rare EGFR Exon 20 Mutation

in Thoracic Oncology

Sabine Zöchbauer-Müller
Bettina Kaserer
Helmut Prosch
Agnieszka Cseh
Flavio Solca
Markus Johann Bauer
Leonhard Müllauer

Frontiers in Oncology

doi 10.3389/fonc.2020.593852

7,101 views
17 citations

Original Research

Published on 25 Jan 2021

Elevated Heterogeneous Nuclear Ribonucleoprotein C Expression Correlates With Poor Prognosis in Patients With Surgically Resected Lung Adenocarcinoma

in Thoracic Oncology

Wei Guo
Qilin Huai
Guochao Zhang
Lei Guo
Peng Song
Xuemin Xue
Fengwei Tan
Qi Xue
Shugeng Gao
Jie He

Frontiers in Oncology

doi 10.3389/fonc.2020.598437

5,242 views
21 citations

Original Research

Published on 19 Jan 2021

Pre-Treatment Tumor Growth Rate Predicts Clinical Outcomes of Patients With Advanced Non-Small Cell Lung Cancer Undergoing Anti-PD-1/PD-L1 Therapy

in Thoracic Oncology

Li-na He
Xuanye Zhang
Haifeng Li
Tao Chen
Chen Chen
Yixin Zhou
Zuan Lin
Wei Du
Wenfeng Fang
Yunpeng Yang

Frontiers in Oncology

doi 10.3389/fonc.2020.621329

8,429 views
18 citations